Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Retina. 2019 May;39(5):948–955. doi: 10.1097/IAE.0000000000002044

Figure 1.

Figure 1

Significant improvement in visual acuity and central subfield thickness (CST) in patients with inflammatory macular edema treated with acetazolamide. A. Visual acuity before (filled circles) and at first follow up (open circles). B. Central subfield thickness obtained from macular optical coherence tomography obtained prior to treatment (filled circles) and at first follow-up (open circles). C. Comparison of initial CST (X axis) and after treatment with acetazolamide (Y axis). Each point represents one patient. The dotted line indicates the case where there was no change in CST.